Original Report

Effects of a self-care education program on quality of life of patients with gastric cancer after gastrectomy


 

Background Gastrectomy affects different aspects of functionality and impacts on the quality of life (QoL) of patients with gastric cancer. The importance of appropriate assessment of QoL in cancer patients is well established, yet strategies that help improve this important patient outcome are relatively scarce.
Objective To examine the effectiveness of a brief self-care education program to improve QoL of gastric cancer patients after gastrectomy.
Methods Using a randomized controlled trial, 59 patients with gastric cancer and candidate for gastrectomy were randomly assigned either to an intervention group (n = 31) to participate in a brief self-care education program or to a usual-care group (n = 28). Data were collected on patient demographics, and QoL was measured by the QLQ-C30 and the QLQ-STO22 at baseline and 1 month after gastrectomy.
Results There were no statistically significant between-group differences in any subscales of the QLQ-C30 and the QLQ-STO22. However, participants in the brief self-care education program showed significant improvements from baseline in the global health status-QoL scale (t = 2.243, P < .05), experience of pain (t = 2.508, P < .05), constipation (t = 2.773, P < .05), and the experience of dysphagia at the follow-up assessment.
Limitations This study is likely to be underpowered to show differences between the groups.
Conclusion A brief self-care education program was not sufficient to significantly improve the quality of life patients with gastric cancer after gastrectomy.
Funding/sponsorship Financial support from the Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Circulating tumor DNA marked progressive liver cancer
MDedge Hematology and Oncology
Assessing progression, impact of radiofrequency ablation in Barrett’s esophagus
MDedge Hematology and Oncology
Biomarkers are being harnessed to improve colorectal cancer detection
MDedge Hematology and Oncology
Olaparib + paclitaxel for metastatic gastric cancer
MDedge Hematology and Oncology
Aspirin, weight loss cut colorectal cancer risk in Lynch syndrome
MDedge Hematology and Oncology
Regorafenib provides low value in metastatic colorectal cancer
MDedge Hematology and Oncology
Life-threatening hypoglycemia resulting from a nonislet cell tumor
MDedge Hematology and Oncology
Genomic oncology: moving beyond the tip of the iceberg
MDedge Hematology and Oncology
Adjuvant oxaliplatin boosts colon cancer survival
MDedge Hematology and Oncology
Ruxolitinib shows promise in refractory metastatic pancreatic cancer
MDedge Hematology and Oncology